MRA Team Science Academic-Industry Partnership AwardClosing Date: 06/10/2021
Funding to enhance translational research by extending academic capabilities to clinical investigations and to facilitate interactions between the academic and industrial research sectors.
The Melanoma Research Alliance (MRA) is a US-based non-profit organisation founded in 2007. Its mission is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.
In general, MRA provides funding for proposals that address the gap in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and patients with melanoma). Successful proposals have the potential of applying important basic and preclinical discoveries to the near-term development of clinical trials and studies impacting melanoma detection, prevention, diagnosis, staging, and/or treatment. MRA welcomes proposals in the following areas:
- Prevention: Elucidation of environmental, epidemiological, and biological factors in melanomagenesis that lead to improved strategies for melanoma prevention.
- Detection, Diagnosis, and Staging: Development of innovative detection and diagnostic methodologies; identification and validation of diagnostic and prognostic biomarkers.
- Treatment: Projects emphasizing the translation of scientific findings to new treatments for patients with melanoma. Examples include, but are not limited to, studies of melanoma immunotherapy, therapeutic applications based on molecular mechanisms involved in melanoma formation and/or progression, treatments that target the tumour microenvironment or microbiome, combination therapies, and development of novel biomarkers of response to therapy.
Special emphasis areas may be formulated for each grant cycle.
The MRA Team Science Academic-Industry Partnership Awards are designed to enhance translational research by extending academic capabilities to clinical investigations and to facilitate interactions between the academic and industrial research sectors. These awards will be co-funded by MRA and an industry partner whose involvement is essential to the project.
|Funding body||Melanoma Research Alliance (MRA)|
|Maximum value||900,000 USD|
|Fund or call||Fund|